Petco stock price target maintained at $3.25 by UBS ahead of Q2 results

Petco Health & Wellness (WOOF) is approaching a critical Q2 earnings report, with investor focus on its ongoing transformation efforts amidst cautious sentiment from firms like UBS, which maintains a Neutral rating and emphasizes the need for market share stabilization. This follows Q1 2025 results where the company missed revenue and EPS forecasts but exceeded adjusted EBITDA expectations, leading to a slight stock increase and BofA raising its price target despite an Underperform rating. The market is closely watching if Petco's strategy to prioritize profitability can translate into sustainable sales growth and competitive resilience.

Analysis

Petco Health & Wellness (WOOF) is at a critical juncture as it approaches its second-quarter earnings, with its ongoing transformation strategy under intense investor scrutiny. The company's first-quarter 2025 results presented a mixed picture, missing both revenue and EPS forecasts with figures of $1.5 billion and -$0.04, respectively. This top-line weakness was evidenced by a 2.3% year-over-year decline in net sales and a 1.3% drop in comparable store sales, validating analyst concerns about market share erosion. However, Petco significantly exceeded profitability expectations, delivering an adjusted EBITDA of $89.4 million, well above the Street's $82 million estimate. This divergence has prompted cautious analyst sentiment; while BofA Securities raised its price target to $2.50 on the EBITDA beat, it maintained an Underperform rating. Similarly, UBS holds a Neutral rating, warning that market patience may be limited and that the company must prove it can build a foundation for future sales growth beyond just improving profitability. A recent S&P credit rating upgrade to 'CCC+' following a debt restructuring provides a modest positive signal for its balance sheet, but it follows a prior downgrade, indicating underlying financial fragility.

Key Decisions for Investors

• Investors should scrutinize the upcoming Q2 results for any stabilization in comparable store sales, as this will be a key indicator of whether Petco's strategy to sacrifice sales for profitability is sustainable or leading to permanent market share loss.
• Given the conflicting signals of a top-line revenue miss against a bottom-line EBITDA beat, a position in WOOF represents a high-risk turnaround play; potential investors must weigh the operational improvements against continued competitive and sales pressures.
• The cautious consensus from analysts, with Neutral or Underperform ratings despite some price target increases, suggests that it may be prudent to await further evidence of a durable recovery before building a significant long position.